Skip to main content
Caplight Logo









United Theranostics

United Theranostics

Private
Bethesda, MarylandHealthcare & Life Scienceshttps://www.unitedtheranostics.com/

Last Round

Early Funding

Jan 26, 2026

Total Funding Raised

$15M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

United Theranostics is a healthcare company that provides molecular imaging and precision radiopharmaceutical therapy services for the treatment of complex cancers.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical Imaging, Biotechnology, Clinical Trials

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

radiopharmaceutical therapytheranosticsmolecular imagingradioligand therapynuclear medicineprecision oncologycancer treatmentPET/CTSPECT/CTtargeted therapyclinical trialsdosimetryoutpatient clinicpersonalized medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

United Theranostics Comparables

Compare United Theranostics with similar companies based on industry and business-model similarity.

United Theranostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Theranostics Centers of America
90%
BAMF Health
84%
McKesson
75%

United Theranostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJan 26, 2026
DebtFeb 11, 2025

Key People

Founding team and executive leadership

Babak Saboury

Co-Founder and Chief Innovation Officer

Founding Team

Rick Long

Chief Executive Officer

Executive Team

Seth Van Voorhees

Chief Financial Officer

Executive Team

United Theranostics Investors

Notable investors and investment history

United Theranostics investors
InvestorRounds
Courage Capital ManagementEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 25, 2026

    Grew 16% QoQ, from 37 to 43 employees.

  • Mar 1, 2026

    Monthly visitors increased 49% MoM.

United Theranostics Filings

Explore SEC and related filing metadata, where available.

United Theranostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about United Theranostics's valuation, stock price, and market status.

Is United Theranostics a public or private company?

United Theranostics is a private company.

What is the current stock price of United Theranostics?

United Theranostics is a private company with no public stock price. No recent secondary market data is available.

How much is United Theranostics worth (valuation)?

Valuation information for United Theranostics is not publicly available.

Can I buy United Theranostics stock?

United Theranostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was United Theranostics's last funding round?

United Theranostics's most recent funding round was Early Funding on January 26, 2026.

Who are the main investors in United Theranostics?

Key investors in United Theranostics include Courage Capital Management.

Will United Theranostics IPO soon?

No public IPO plans have been announced for United Theranostics.

How can I track United Theranostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor United Theranostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBethesda, Maryland
Employee Range44
Year Founded2006
Last FundingJan 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?